ClinicalTrialsFinder

GD2 Antibody (Naxitamab) Clinical Trials in Guanzhou, Guangdong

1 recruitingGuanzhou, Guangdong, China

Showing 1–1 of 1 trials

Recruiting

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma

NeuroblastomaGD2 Antibody (Naxitamab)
Guangzhou Women and Children's Medical Center64 enrolled1 locationNCT06574698